ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

NIH Review Process A Disaster, Borek Says

October 19, 1979

In Brief: Harris says She Won’t Ease up On Califano’s Antismoking Campaign – It Cost Him His Job

July 27, 1979

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

House Members Express Support for Cancer Program

September 12, 1980

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014